CME Information
Provider Statement
This CME, CNE, AAPA continuing education activity is provided by 
This continuing pharmacy education activity is provided by 
Support Statement
This activity is supported by educational grants from Biogen; Sanofi Genzyme; and TG Therapeutics, Inc.
Target Audience
The intended audience for this activity is neurologists, neurology nurses, pharmacists, physician assistants, and other health care professionals involved in the management of patients with multiple sclerosis.
Learning Objective
Upon successful completion of this activity, participants should be better able to assess the latest clinical evidence in order to determine the most appropriate disease-modifying therapies (DMTs) in women with MS during the family planning process.
Activity Chair
Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director
Multiple Sclerosis Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY
Faculty
Patricia Melville, MSN, NP-C, MSCN
Clinical Instructor
Stony Brook MS Comprehensive Care Center
State University of New York
Stony Brook, NY
Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
June Halper, MSN, APN-C, MSCN, FAAN
Laurie Scudder, DNP, NP
Accreditation
In support of improving patient care, The Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Consortium of Multiple Sclerosis Centers designates this activity for 0.25 contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
This program is acceptable for 0.25 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-9999-21-016-H01-P, effective 7/30/21. This is a knowledge-based activity, and there is no fee to attend.
The Consortium of Multiple Sclerosis Centers has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until July 29, 2022. PAs should only claim credit commensurate with the extent of their participation.
This enduring material is approved for 1 year from the date of original release, July 30, 2021 to July 29, 2022.
How to Participate in This Activity and Obtain CE Credit
To participate in this CE activity, you must read the learning objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, The Consortium of Multiple Sclerosis Centers will issue an AMA PRA Category 1 Credit(s)™ Certificate, Nurse CE Certificate, or AAPA Category 1 CME certificate; or Vindico Medical Education will issue a CPE statement of credit. Pharmacist learners who submit their NABP and DOB will be reported to the CPE Monitor by Vindico Medical Education directly.
Disclosures
Both the Consortium of Multiple Sclerosis Center and Vindico Medical Education adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Activity Chair and Faculty report the following relationship(s)
Patricia K. Coyle, MD, FAAN, FANA
Consulting Fee: Accordant, Biogen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Novartis, Sanofi Genzyme, Viela Bio
Speakers Bureau: Biogen, Janssen
Contracted Research: Actelion, Alkermes, Corrona, Genentech, MedDay, NINDS, Novartis
Patricia Melville, MSN, NP-C, MSCN
Consulting Fee: Biogen, Bristol Myers Squibb, EMD Serono, Novartis, Genentech, Sanofi Genzyme
Speakers Bureau: Alexion, Biogen, Bristol Myers Squibb, EMD Serono, Novartis, Sanofi Genzyme
Contracted Research: Biogen, Corrona, Genentech, Johnson & Johnson, MedDay, Novartis
Reviewers report the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Has disclosed no relevant financial relationships.
Jennifer Frederick, PharmD, BCPS
Has disclosed no relevant financial relationships.
June Halper, MSN, APN-C, MSCN, FAAN
Has disclosed no relevant financial relationships.
Laurie Scudder, DNP, NP
Has disclosed no relevant financial relationships.
The Consortium of Multiple Sclerosis Centers and Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.
Copyright Statement
Co-Created and published by The Consortium of Multiple Sclerosis Centers and Vindico Medical Education. Printed in the USA. Copyright © 2021 Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. All rights reserved. No part of this publication may be reproduced without written permission from the publishers. The material presented at or in any of The Consortium of Multiple Sclerosis Centers and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of The Consortium of Multiple Sclerosis Centers or Vindico Medical Education. Neither The Consortium of Multiple Sclerosis Centers, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME/CNE/AAPA Questions?
Contact us at education@mscare.org
CPE Questions?
Contact us at cme@vindicoCME.com